KYMR Stock: Price, Earnings History and SEC Filings
Kymera Therapeutics, Inc. (KYMR) last traded at $126.63, up 3.29% on the latest session and up 13.3% over the past month. In its most recent reported quarter (Sep 2026) earnings per share were $-1.32 against an analyst estimate of $-1.26, a miss of 4.8%.
$126.63 +3.29%
1 month+13.27%
52-week high$130.05
52-week low$55.66
Volume1.59M
ExchangeNasdaqGM
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
KYMR earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Sep 2026 | Oct 29, 2026 | $-1.32 | $-1.26 | -4.76% |
| Jun 2026 | Aug 5, 2026 | $-0.62 | $-0.64 | +3.13% |
| Mar 2026 | Apr 30, 2026 | $-0.71 | $-0.89 | +20.22% |
| Dec 2025 | Feb 26, 2026 | $-0.97 | $-0.77 | -25.97% |
KYMR beat the analyst EPS estimate in 2 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for KYMR
SEC filing data is not available right now. You can search for KYMR on SEC EDGAR.
KYMR news
- Kymera Therapeutics, Inc. Q3 2026 Earnings Call SummaryOct 29, 2026 · app.moby.co
- Kymera (KYMR) Q3 2026 Earnings Call TranscriptOct 29, 2026 · fool.com
- Kymera Therapeutics Q3 Earnings Call HighlightsOct 29, 2026 · marketbeat.com
- Kymera Therapeutics Announces Third Quarter 2026 Financial Results and Reports Positive Results from the KT-579 Phase 1 Healthy Volunteer TrialOct 29, 2026 · finance.yahoo.com
- Kymera Therapeutics to Announce KT-579 Phase 1 Healthy Volunteer Trial Results on October 29, 2026Oct 28, 2026 · finance.yahoo.com
- Kymera Therapeutics (KYMR) Nears Earnings With KT 621 In Focus, Is The Stock Still Cheap?Oct 27, 2026 · finance.yahoo.com
- Could You Have Seen The Run In Kymera Stock Coming?Oct 26, 2026 · trefis.com
- Will Axsome Therapeutics (AXSM) Report Negative Earnings Next Week? What You Should KnowOct 26, 2026 · finance.yahoo.com
About Kymera Therapeutics, Inc.
Kymera Therapeutics, Inc. (KYMR) is a US-listed public company on Nasdaq.